Novartis AG
SIX:NOVN

Watchlist Manager
Novartis AG Logo
Novartis AG
SIX:NOVN
Watchlist
Price: 90.63 CHF 0.19% Market Closed
Market Cap: 179B CHF

Intrinsic Value

The intrinsic value of one NOVN stock under the Base Case scenario is 84.51 CHF. Compared to the current market price of 90.63 CHF, Novartis AG is Overvalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

NOVN Intrinsic Value
84.51 CHF
Overvaluation 7%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Novartis AG

NOVN
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for NOVN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Novartis AG
SIX:NOVN
CH
Pharmaceuticals
Market Cap
183.5B CHF
IPO
May 7, 2001
CH
Pharmaceuticals
Market Cap
183.5B CHF
IPO
May 7, 2001
Price
CHffalse
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about NOVN?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Novartis AG
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Novartis AG

Current Assets 25.7B
Cash & Short-Term Investments 8B
Receivables 8.5B
Other Current Assets 9.2B
Non-Current Assets 71.8B
Long-Term Investments 2.1B
PP&E 10.6B
Intangibles 53B
Other Non-Current Assets 6.1B
Efficiency

Free Cash Flow Analysis
Novartis AG

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Novartis AG

Revenue
51.7B USD
Cost of Revenue
-12.8B USD
Gross Profit
38.9B USD
Operating Expenses
-22.6B USD
Operating Income
16.3B USD
Other Expenses
-4.4B USD
Net Income
11.9B USD
Fundamental Scores

NOVN Profitability Score
Profitability Due Diligence

Novartis AG's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Exceptional 3-Year Average ROE
Positive Net Income
67/100
Profitability
Score

Novartis AG's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

NOVN Solvency Score
Solvency Due Diligence

Novartis AG's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
67/100
Solvency
Score

Novartis AG's solvency score is 67/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NOVN Price Targets Summary
Novartis AG

Wall Street analysts forecast NOVN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NOVN is 104.65 CHF with a low forecast of 82.82 CHF and a high forecast of 124.95 CHF.

Lowest
Price Target
82.82 CHF
9% Downside
Average
Price Target
104.65 CHF
15% Upside
Highest
Price Target
124.95 CHF
38% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for NOVN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

NOVN Insider Trading
Buy and sell transactions by insiders

NOVN News

Other Videos
What is the Intrinsic Value of one NOVN stock?

The intrinsic value of one NOVN stock under the Base Case scenario is 84.51 CHF.

Is NOVN stock undervalued or overvalued?

Compared to the current market price of 90.63 CHF, Novartis AG is Overvalued by 7%.

Back to Top